Trial Profile
An open label phase I study of humanized human milk fat globule-1 (huHMFG1) [R 1550; AS 1402] antibody in patients with locally advanced or metastatic breast cancer (TOPCAT)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs BTH 1704 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Acronyms TOPCAT
- 31 Aug 2005 New trial record.